COMMUNIQUÉS West-GlobeNewswire
 
      -   
  LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 202401/05/2024
-   
  Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems01/05/2024
-   
  MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 202401/05/2024
-   
  Koelis Announces New Product Release at AUA 2024 to Offer Innovative AI-Enhanced MRI Fusion Biopsy Workflow01/05/2024
-   
  Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond01/05/2024
-   
  Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone01/05/2024
-   
  WAKE RADIOLOGY TEAM RALLIES TO SUPPORT TRIANGLE RACE FOR THE CURE01/05/2024
-   
  Seasoned Physician Executive Joins Nymbl Science01/05/2024
-   
  Simms/Mann Family Foundation Recognizes Extraordinary Nurses in Second Year of “Off the Chart: Rewarding Nursing Greatness” Campaign01/05/2024
-   
  Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ01/05/2024
-   
  H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors01/05/2024
-   
  Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)01/05/2024
-   
  Aeroflow Health Announces Expanded Access to Lactation Consultants, Supporting New Mothers Across all 50 States01/05/2024
-   
  The Pediatric Brain Tumor Foundation Welcomes Dr. Sanjay Gupta to its Board of Directors01/05/2024
-   
  Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargardt Patients During the ARVO 2024 Annual Meeting May 5-901/05/2024
-   
  WeightWatchers for Business and Personify Health Partner to Help Employers Address Weight Health Care01/05/2024
-   
  SFWJ/MedCana Reacts to US DEA's Rescheduling of Marijuana01/05/2024
-   
  Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation01/05/2024
-   
  Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million01/05/2024
Pages